TABLE 6.
Multiple regression analysis between plasma α-tocopherol (normalized for total cholesterol) or urinary metabolites and covariates in all subjects (n = 233)1
α-CEHC (μmol/g) |
α-CMBHC (μmol/g) |
Plasma α-tocopherol (mmol/mol) |
||||
Regression coefficient | 95% CI | Regression coefficient | 95% CI | Regression coefficient | 95% CI | |
Dietary α-tocopherol (mg/d) | 0.0862 | 0.047, 0.125 | 0.018 | 0.010, 0.027 | 0.0842 | 0.059, 0.109 |
Plasma α-tocopherol (mmol/mol) | 0.8202 | 0.646, 0.994 | 0.0732 | 0.034, 0.112 | ||
Plasma lipids (mg/dL) | ||||||
Total cholesterol | −0.0332 | −0.047, −0.0199 | −0.0042 | −0.007, −0.001 | 0.0392 | 0.031, 0.048 |
Triglycerides | −0.0142 | −0.022, −0.006 | −0.001 | −0.003, 0.001 | 0.0192 | 0.013, 0.024 |
BMI | ||||||
Overweight, 25–30 kg/m2 | −0.718 | −1.736, 0.300 | 0.034 | −0.198, 0.266 | 0.045 | −0.717, 0.807 |
Obese, >30 kg/m2 | −0.711 | −1.882, 0.461 | −0.122 | −0.386, 0.141 | −0.485 | −1.358, 0.388 |
Age | ||||||
30–50 y | 0.323 | −0.661, 1.307 | 0.145 | −0.077, 0.367 | 0.354 | −0.383, 1.091 |
>50 y | 0.522 | −0.714, 1.758 | 0.252 | −0.029, 0.534 | 0.928 | 0.008, 1.849 |
Female | 0.359 | −0.565, 1.284 | 0.044 | −0.168, 0.256 | 0.215 | −0.476, 0.905 |
African American | 0.070 | −0.865, 1.004 | −0.104 | −0.317, 0.109 | −0.329 | −1.031, 0.374 |
Energy intake (kcal) | 0.230 | −0.215, 0.675 | 0.050 | −0.053, 0.154 | −0.198 | −0.552, 0.156 |
CEHC, carboxyethyl hydroxychroman; CMBHC, carboxymethylbutyl hydroxychroman.
Significant regression coefficients (P < 0.05).